Unknown Antiplatelet drug acting via purinergic receptors, not largely impacted by CYP2C19 polymorphism is: A Ticlopidine B Prasugrel C Clopidogrel D Abciximab 💡 Explanation Antiplatelet drug acting via purinergic receptors, not largely impacted by CYP2C19 polymorphism is: ✓ Correct Answer: B. Prasugrel